AI Buyer Insights:

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

List of Vimachem Optimz Pharma Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Old Product New Product Category When SI
Aspen Pharmacare Australia Life Sciences 600 $429M Australia Vimachem Legacy Vimachem Optimz Pharma Manufacturing Execution System 2018 n/a
Elpen Pharmaceutical Co. Life Sciences 816 $112M Greece Vimachem Legacy Vimachem Optimz Pharma Manufacturing Execution System 2024 n/a
Iberfar Life Sciences 118 $10M Portugal Vimachem Legacy Vimachem Optimz Pharma Manufacturing Execution System 2021 n/a
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating Vimachem Optimz Pharma

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Vimachem Optimz Pharma. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Vimachem Optimz Pharma Coverage

Vimachem Optimz Pharma is a Manufacturing Execution System solution from Vimachem.

Companies worldwide use Vimachem Optimz Pharma, from small firms to large enterprises across 21+ industries.

Organizations such as Aspen Pharmacare Australia, Elpen Pharmaceutical Co. and Iberfar are recorded users of Vimachem Optimz Pharma for Manufacturing Execution System.

Companies using Vimachem Optimz Pharma are most concentrated in Life Sciences, with adoption spanning over 21 industries.

Companies using Vimachem Optimz Pharma are most concentrated in Australia, Greece and Portugal, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Vimachem Optimz Pharma across Americas, EMEA, and APAC.

Companies using Vimachem Optimz Pharma range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 100%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 0%.

Customers of Vimachem Optimz Pharma include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Vimachem Optimz Pharma customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Manufacturing Execution System.